Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Is ATEV the first scalable alternative to autologous fistulas in hemodialysis access Can Humacyte, Inc. turn ATEV into a viable dialysis access alternative? Dive into Phase 3 signals, risks, and market impact shaping its future. bySoujanya RaviApril 30, 2026